Searched for
CLINICAL TRIAL COSTS
Bharat Biotech is 'back in action' after Covid reset: Krishna Ella on TB vaccine, Nipah-Ebola shots, gene therapy, IPO plans & what’s nextBharat Biotech is “back in action” after a two-year post-Covid reset, founder Krishna Ella says, with the company expanding beyond vaccines...22 Sep, 2026, 01.49 PM IST- Wegovy maker Novo Nordisk faces investor pressure to find growth beyond weight-loss drugsFacing increased scrutiny, Novo Nordisk must clarify its future strategy outside of its leading weight-loss drug. Investors are advocating ...21 Sep, 2026, 11.36 AM IST
- Agonisingly slow clinical trial is stopping Indian pharma become global innovator from supplierIndia's regulatory hurdles slow down early-stage drug trials significantly. This complexity causes Indian companies to conduct crucial firs...16 Sep, 2026, 12.13 AM IST
- Huawei plans for more AI pharma tie-ups, says healthcare presidentThe move highlights Huawei's ambitions to gain a foothold in the fast-growing AI drug discovery market, where pharmaceutical companies are ...27 Aug, 2026, 02.03 PM IST
- Bernie Marcus was fired from his job in 1978, then built Home Depot and an $11 billion fortune — now his foundation is putting nearly $30 million into heart research, reviving his early dream of medicineBernie Marcus was fired from Handy Dan in 1978, a setback that helped push him toward cofounding Home Depot and building an $11 billion for...16 Aug, 2026, 07.33 PM IST
- Bengaluru-based startup leans on cancer-sniffing dogs and AI for early detectionBilly, Jessie and Banu are part of a team of beagles, labradors, Dutch shepherds and other dog breeds being trained by startup Dognosis to ...14 Aug, 2026, 09.18 AM IST
- For kidney patients, the biggest change may be coming: New artificial kidney implant will filter blood continuosly without regular hospital dialysisFor kidney patients, the biggest change may be coming in the form of Holly, a surgically implanted artificial kidney designed to filter blo...12 Aug, 2026, 12.16 PM IST
- Jubilant Pharmova shares decline 6% after Q1 profits falls 45% YoYJubilant Pharmova shares fell after Q1 profit plunged 45% YoY to Rs 56 crore, despite revenue rising 17% to Rs 2,229 crore. The profit decl...11 Aug, 2026, 08.36 PM IST
- In 2017, two parents asked scientist Stanley Crooke to create treatments for their children's rare mutations. Years later, a custom drug cut one boy's seizures by 90% and helped him walk on his own for the first timeMedicine is undergoing a profound transformation by shifting focus from populations to individual patients. A novel custom drug for rare ge...10 Aug, 2026, 08.25 PM IST
- Forget Nvidia chips, China's next big race is being slowed down by an unlikely rival: monkeysLab primate prices in China have surged over 1,000% in eight years, with a single cynomolgus macaque now costing around Rs 22 lakh. The sho...07 Aug, 2026, 01.20 PM IST
- In 2009, a Navy veteran's low-cost invention helped thousands get glasses in places without eye doctorsUSee Vision Kit: Retired US Navy and Marine Corps officer, Kevin White, has pioneered a vision testing system aimed at providing affordable...03 Aug, 2026, 11.45 PM IST
- Can you get rid of cavities without drilling? Scientists find an 'easy and inexpensive' way to treat tooth decay in secondsA new study highlights silver diamine fluoride as a quick, painless dental treatment. This liquid application effectively stops early child...31 Jul, 2026, 11.21 AM IST
- Bye-bye painful dentist visit: A simple liquid could stop tooth decay; no drilling or injections needed for many cavitiesA major US clinical trial has found that silver diamine fluoride, a liquid painted onto cavities in seconds, stopped tooth decay in more th...30 Jul, 2026, 12.15 PM IST
- Can AI shorten India's rare disease diagnosis journey? New tool aims to do just thatSanofi has launched AccelRare, an AI tool aiding doctors in rare disease pre-diagnosis. This platform generates potential diagnoses within ...28 Jul, 2026, 04.24 PM IST
- FDA approves at-home starter dose of Eisai-Biogen Alzheimer's drugThe US FDA approved an at-home starting dose for Eisai and Biogen's Alzheimer's drug. This new subcutaneous formulation allows patients to ...14 Jul, 2026, 08.41 AM IST
- Pharma body renews push for data protectionLeading pharmaceutical companies seek Regulatory Data Protection to boost research investments. Public health groups and local makers oppos...13 Jul, 2026, 12.23 AM IST
- Clinical trials on naive Indians zoomNumber of clinical trials conducted by global pharma companies in India double in a year.18 Jul, 2007, 05.30 AM IST
Load More
